Termination Agreement, dated as of April 30, 2018, by and between the Registrant and Dr. Michelle Dipp

You and OvaScience, Inc. (the “Company”) are parties to that certain Advisory Agreement governing your advisory services to the Company dated June 21, 2017 (as amended August 3, 2017) (the “Advisory Agreement”). We have agreed to terminate the Advisory Agreement in accordance with the terms set forth herein.

As further described herein, we agree to the following terms, which have been approved by our Board of Directors:

The Advisory Agreement and your advisory services to the Company will be terminated as of the date hereof. You acknowledge you have been fully paid for your services through December 31, 2017 in accordance with Section 1(c)(i) of the Advisory Agreement and that you agree to forego the $250,000 retainer due to you for the period beginning January 1, 2018 and ending December 31, 2018 under Section 1(c)(ii) of the Advisory Agreement.

You agree to waive the discretionary cash bonus for Fiscal 2017 based on your 2017 performance in the amount of up to $300,000 that you were entitled to under your employment agreement with the Company dated January 5, 2016 (the “Employment Agreement”) and that you continued to be eligible to receive under Section 1(c)(iv) of the Advisory Agreement.

Notwithstanding anything set forth in the Advisory Agreement, all outstanding options granted to you prior to the date hereof set forth on Exhibit A hereto (the “Outstanding Options”), shall become 100% fully vested and shall remain exercisable until each Outstanding Option’s Expiration Date set forth on Exhibit A, and otherwise in accordance with their terms.

Sincerely,

Name: Chris Kroeger

Title: CEO

The foregoing correctly sets forth the terms regarding the termination of my Advisory Agreement with OvaScience, Inc. I am not relying on any representation other than those set forth above.

/s/ Michelle Dipp        April 30, 2018    

Michelle Dipp, M.D.    Date